Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Treating Gum Disease Might Help Prostate Symptoms: Study

Treating gum disease may help reduce symptoms of prostate inflammation, which can make urination difficult, a small study suggests. Previous research has shown a link between gum disease and prostate inflammation -- called prostatitis. The study included 27 men, age 21 and older, who had prostatitis and moderate to severe gum disease. The men underwent...

Posted today in Medical

Diet and Exercise May Not Stave Off Age-Related Muscle Loss

It's not clear whether diet and exercise can prevent muscle loss as people age, a new British review finds. People lose 30 percent to 50 percent of their muscle mass between the ages of 40 and 80, according to the study authors. Muscle loss can lead to reduced strength, more difficulty doing everyday tasks, and increased health care needs and costs,...

Posted 3 days ago in New Drug Approvals

FDA Approves Invega Trinza (paliperidone palmitate) Four-Times-A-Year Treatment for Schizophrenia

TITUSVILLE, N.J., May 19, 2015 – There’s a new treatment option for schizophrenia – Invega Trinza (three-month paliperidone palmitate), the first and only schizophrenia medication to be administered just four times a year, providing the longest dosing interval available. Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and...

Posted 3 days ago in Clinical Trials

Ardelyx Presents Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C

Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo....

Posted today in Medical

Depression May Intensify Anger in Veterans With PTSD: Study

Anger often escalates quickly in veterans with post-traumatic stress disorder (PTSD) when they're depressed, a new study reveals. "Our study findings should draw attention to anger as a major treatment need when military service members screen positive for PTSD or for depression, and especially when they screen positive for both," lead researcher Raymond...

Posted today in Medical

Fish Oil Tied to Better Brain Function in Older Adults

Consuming more omega-3 fatty acids -- found in many types of fish -- may benefit people at risk for Alzheimer's disease, a new study suggests. Researchers looked at 40 mentally healthy adults, aged 65 to 75, who had the gene variant APOE e4, which put them at risk for late-onset Alzheimer's. Those who consumed higher amounts of two omega-3 fatty acids...

Posted today in Medical

Can Asthma Protect Men From Prostate Cancer?

A new study suggests, but does not prove, that men with asthma may be less likely to develop aggressive prostate cancer or to die from the disease. Researchers found that men with asthma were 29 percent less likely to develop aggressive prostate cancer. And they were 36 percent less likely to die from the disease, according to the study. However,...

Posted today in Medical

Young Athletes With ACL Injuries Often Need Repeat Surgery: Study

Many young athletes who undergo surgery for a torn anterior cruciate ligament (ACL) need a second operation later on, a new study shows. Torn ACLs are widespread among people younger than 21, said researchers at the Hospital for Special Surgery in New York City. "This is the first study to evaluate, on a population level, the percentage of patients...

Posted today in Medical

Raw Tuna Suspected as Source of Salmonella Outbreak: CDC

Raw tuna is suspected as the source of a salmonella outbreak that has now sickened 53 people in nine states, according to U.S. health officials. No deaths have been reported. But 10 people have been sick enough to be hospitalized, the U.S. Centers for Disease Control and Prevention said Thursday in a statement. The majority of those who fell ill said...

Posted today in Medical

Low-Income Southerners at Highest Risk for Vision Loss

New U.S. government research connects eyesight problems with poverty, and reveals that people in the southern part of the country have the highest prevalence of both poverty and severe vision loss. In fact, most of the counties that rank in the top 25 percent for severe vision loss and poverty are in the South, according to Dr. Jinan Saaddine, team...

Read more news...

Recently added consumer and prescribing information: Kybella, Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web1)